UBS Group’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.4M | Buy |
97,500
+34,000
| +54% | +$7.16M | ﹤0.01% | 2684 |
|
|
2025
Q4 | $12.6M | Hold |
63,500
| – | – | ﹤0.01% | 3051 |
|
|
2025
Q3 | $12.9M | Buy |
63,500
+9,200
| +17% | +$1.63M | ﹤0.01% | 3022 |
|
|
2025
Q2 | $9.56M | Buy |
54,300
+33,200
| +157% | +$5M | ﹤0.01% | 3123 |
|
|
2025
Q1 | $2.84M | Sell |
21,100
-124,300
| -85% | -$16.4M | ﹤0.01% | 4371 |
|
|
2024
Q4 | $18.4M | Sell |
145,400
-45,400
| -24% | -$6.75M | ﹤0.01% | 2419 |
|
|
2024
Q3 | $31.7M | Buy |
190,800
+53,600
| +39% | +$8.11M | 0.01% | 1477 |
|
|
2024
Q2 | $18.3M | Buy |
137,200
+19,100
| +16% | +$2.3M | ﹤0.01% | 1760 |
|
|
2024
Q1 | $12.4M | Sell |
118,100
-75,000
| -39% | -$6.74M | ﹤0.01% | 2086 |
|
|
2023
Q4 | $14.6M | Buy |
193,100
+107,900
| +127% | +$6.84M | ﹤0.01% | 1815 |
|
|
2023
Q3 | $5.61M | Buy |
+85,200
| New | +$6.37M | ﹤0.01% | 2460 |
|
|
2023
Q1 | – | Sell |
-40,000
| Closed | -$1.95M | – | 10364 |
|
|
2022
Q4 | $1.95M | Buy |
40,000
+20,000
| +100% | +$924K | ﹤0.01% | 3410 |
|
|
2022
Q3 | $1.03M | Hold |
20,000
| – | – | ﹤0.01% | 3733 |
|
|
2022
Q2 | $1.05M | Hold |
20,000
| – | – | ﹤0.01% | 3697 |
|
|
2022
Q1 | $1.72M | Hold |
20,000
| – | – | ﹤0.01% | 3584 |
|
|
2021
Q4 | $1.63M | Hold |
20,000
| – | – | ﹤0.01% | 3925 |
|
|
2021
Q3 | $1.33M | Hold |
20,000
| – | – | ﹤0.01% | 3937 |
|
|
2021
Q2 | $1.34M | Hold |
20,000
| – | – | ﹤0.01% | 3930 |
|
|
2021
Q1 | $1.04M | Buy |
20,000
+9,000
| +82% | +$455K | ﹤0.01% | 4209 |
|
|
2020
Q4 | $439K | Hold |
11,000
| – | – | ﹤0.01% | 4698 |
|
|
2020
Q3 | $270K | Buy |
11,000
+6,000
| +120% | +$153K | ﹤0.01% | 4614 |
|
|
2020
Q2 | $91K | Buy |
+5,000
| New | +$98.5K | ﹤0.01% | 5376 |
|
|
2017
Q2 | – | Sell |
-8,500
| Closed | -$151K | – | 7981 |
|
|
2017
Q1 | $151K | Buy |
+8,500
| New | +$158K | ﹤0.01% | 4815 |
|
|
2016
Q1 | – | Sell |
-100
| Closed | -$3K | – | 8165 |
|
|
2015
Q4 | $3K | Hold |
100
| – | – | ﹤0.01% | 7901 |
|
|
2015
Q3 | $4K | Sell |
100
-100
| -50% | -$5.17K | ﹤0.01% | 7843 |
|
|
2015
Q2 | $12K | Hold |
200
| – | – | ﹤0.01% | 7320 |
|
|
2015
Q1 | $10K | Sell |
200
-800
| -80% | -$37.4K | ﹤0.01% | 7644 |
|
|
2014
Q4 | $51K | Buy |
+1,000
| New | +$52.3K | ﹤0.01% | 6465 |
|
Other funds holding THC
VPM
VCM
LPC
UBS Group's THC Position: Q1 2026 in Review
UBS Group reduced its Tenet Healthcare (THC) stake by 24% in Q1 2026, selling an estimated $22.7M and leaving 336,280 shares worth $63.5M. The position accounts for 0.01% of the portfolio, ranked #1402.
UBS Group first reported a position in THC in Q4 2014 and has held it in 46 quarters since. The position peaked at $99.9M in Q3 2025. 691 funds tracked by Wall St. Rank hold THC as of Q1 2026.
- UBS Group held 336,280 shares of Tenet Healthcare worth $63.5M as of Q1 2026.
- UBS Group sold 107,786 Tenet Healthcare shares in Q1 2026, an estimated $22.7M.
- Tenet Healthcare made up 0.01% of UBS Group's portfolio in Q1 2026, its #1402 holding.
- UBS Group first reported a position in Tenet Healthcare in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Tenet Healthcare position peaked at $99.9M in Q3 2025.
- 691 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.